Chrysos Corp. Ltd. · ASX:C79

Chrysos — Q2 FY2024 Earnings Presentation

21 slides from Chrysos's earnings presentation, Jan 24, 2024

  1. Slide 1: Replacement of FY24 Q2 Quarterly presentation

    Faster, more accurate gold analysis 24 January 2024 Replacement of FY24 Q2 Quarterly presentation Chrysos Corporation Ltd (ASX:C79) (“Chrysos” or the “Company) advises its FY24 Q2 Quarterly presentation lodged earlier today, 24 January, had an incorrect unit figure on slide 4. Bullet point 3 on slid

  2. Slide 2: Faster, more accurate gold analysis

    For personal use only Faster, more accurate gold analysis Q2 FY24 - Quarterly Investor Update 24 January 2024 Dirk Treasure, Managing Director and CEO Brett Coventry, CFO

  3. Slide 3: Important notice

    Important notice For personal use only The material in this presentation has been prepared by Chrysos Corporation Limited (ASX: C79) (“Chrysos” or the “Group") and is general background information about Chrysos’ current activities as at the date of this presentation. The information is given in sum

  4. Slide 4: Financial and operating highlights

    Financial and operating highlights Q2 FY24 Total Revenue1 of $10.1m, reflecting 57% growth YoY For personal use only $10.1m 1.0m Total Revenue1 Samples Processed • MMAP Revenue of $8.9m, AAC Revenue of $1.2m • +29% growth YoY • +57% growth on YoY, +13% growth QoQ • +1% growth QoQ • +63% growth YoY,

  5. Slide 5: Top line momentum continuing

    Top line momentum continuing Secure forecastable revenue accounts for 88% of Q2 FY24 Unaudited Total Revenue For personal use only Unaudited MMAP, AAC and Other Income +63% (MMAP +AAC only) ■ Minimum Monthly Assay Payments (MMAP) provide predictable and $11,000 sustainable minimum revenue $10,000 $9

  6. Slide 6: Sample volume growth

    Sample volume growth Ongoing adoption by global miners will drive quarterly volume growth For personal use only Average Unit Utilisation & Samples Processed Strategically located ■ A growing network of units in global mining hubs provides revenue up-side ■ Western Australian Goldfields ■ Golden Tria

  7. Slide 7: Executing on our global PhotonAssay roll out

    Executing on our global PhotonAssayTM roll out Strong and sustainable growth underpinned by roll out of contracted units across the globe For personal use only 25 Units Deployed1 Offices & Regions with PhotonAssayTM enquiries Deployed or installing regions Manufacturing 1. As of 24 January 2024 CHRY

  8. Slide 8: Strong balance sheet to drive growth

    Strong balance sheet to drive growth Successful Placement of $75m and increased debt facility to $95m For personal use only $85m $95m Cash balance CBA debt facility ▪ Institutional Placement raising $75 million ▪ Additional $65 million debt facility with (before costs) the Commonwealth Bank of Austr

  9. Slide 9: Chrysos, Barrick and MSALABS partnership

    Chrysos, Barrick and MSALABS partnership Global partnership for delivery of PhotonAssayTM to Barrick mine sites across four continents For personal use only Chrysos Barrick Gold MSALABS Faster, more accurate + One of the world’s largest + Fast-growing international laboratory business gold analysis

  10. Slide 10: In summary

    In summary Chrysos PhotonAssayTM well positioned for sustainable growth For personal use only ■ Continued top line growth in Q2 FY24: ■ 13% QoQ increase in Total Revenue1 ■ 57% YoY increase in Total Revenue1 ■ 49 PhotonAssayTM units deployed or contractually-committed ■ 25 units deployed2, with 2 cu

  11. Slide 11: About Chrysos

    For personal use only About Chrysos [Insert]

  12. Slide 12: Chrysos – revolutionising the global mining industry

    Chrysos – revolutionising the global mining industry Chrysos is a global provider of novel assay services through its proprietary PhotonAssayTM technology For personal use only Disruptive Minerals Analysis Service and Lease Model with Industry Accepted Technology Technology Tier 1 Counterparties Dis

  13. Slide 13: Our commercialisation journey

    Our commercialisation journey The outcome of 20+ years of research and development For personal use only Prototype Complete JORC and NI43-101 New Customer International deployment 1st PhotonAssayTM Max unit Companies cite PhotonAssayTM Announcements continues data in market announcements Barrick Bul

  14. Slide 14: The Chrysos Vision

    The Chrysos Vision To become the world’s leading provider of innovative assay services and technologies For personal use only Market Challenge: Traditional assay techniques are slow, labour intensive, complex, destructive to the assay sample, and involve Fully-quantitative analysis in as little as 2

  15. Slide 15: High barriers to entry

    High barriers to entry High barriers to entry supported by global IP rights For personal use only Barriers to competitive entry Long-term leases with Protected by global guaranteed minimums, IP rights embedded at customer site 20+ years of R&D and Superior product to the investment in technology alt

  16. Slide 16: PhotonAssay technology

    PhotonAssayTM technology Best in class gold assaying with measurable benefits over traditionally used methods For personal use only PhotonAssayTM vs. Traditional Fire Assay1 PhotonAssayTM value proposition Fire Assay PhotonAssayTM Faster turnaround Lower costs Simple to operate Results in as little

  17. Slide 17: Delivering tangible benefits for miners

    Delivering tangible benefits for miners PhotonAssayTM enables timely decision making and additional gold recovery For personal use only The opportunity… PhotonAssayTM is embedded in the mining value chain PhotonAssayTM Value Add ■ Each year global miners are Exploration Fast turnaround for mine esti

  18. Slide 18: An environmentally-friendly solution

    An environmentally-friendly solution Substantially better for the environment and significantly safer than fire assay For personal use only PhotonAssayTM has a substantial positive environmental impact that will continue to grow in tandem with the uptake of the technology ✓ PhotonAssayTM reduces CO2

  19. Slide 19: Large & unpenetrated TAM

    Large & unpenetrated TAM Assay expenditure is a non-discretionary operating cost For personal use only Existing PhotonAssayTM Reach TAM for PhotonAssayTM Units 700 610 Units 600 500 PhotonAssayTM Unit 410 On-site 400 Laboratories +561 Units Units 300 200 Off-site 100 200 Laboratories Offices & Regio

  20. Slide 20: Experienced leadership team

    Experienced leadership team Supported by a well-respected and tenured board For personal use only Senior leadership team Board of Directors Dirk Treasure Rob Adamson Kerry Gleeson Founding CEO & Managing Director Founder & Chairman Director • Metallurgist with a background in both • 20+ years’ exper

  21. Slide 21: Thank you

    Thank you For personal use only For more information, please visit chrysoscorp.com or contact us at investors@chrysoscorp.com

Chrysos — Q2 FY2024 Earnings Presentation on 6ix